The "drug vs graft-vs-host disease" conundrum gets tougher, but there is an answer: The challenge to dermatologists

Archives of Dermatology

Volumn 137, Issue 1, 2001, Pages 75-76

  Nghiem, P ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

BONE MARROW TRANSPLANTATION; EDITORIAL; EOSINOPHIL; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; MEDICAL SPECIALIST; MORBIDITY; MORTALITY; PRIORITY JOURNAL; SKIN BIOPSY; SKIN MANIFESTATION;

ACUTE DISEASE; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS;

EID: 0035143231     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (9)

1. Uses and growth of hematopoietic cell transplantation
2. Graft-versus-host disease
3. A retrospective analysis of therapy for acute graft-versus-host disease: Initial treatment
4. Late appearance of acute graft-vs-host disease after suspending or tapering immunosuppressive drugs
5. Value of skin biopsies in assessing prognosis and progression of acute graft-versus-host disease
6. "Rush" skin biopsy specimens in a tertiary medical center
7. Clinical significance of skin biopsies in the diagnosis and management of graft-vs-host disease in early postallogeneic bone marrow transplantation
8. A reappraisal of the histopatnologic criteria for the diagnosis of cutaneous allogeneic acute graft-vs-host disease
9. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease